XML 29 R15.htm IDEA: XBRL DOCUMENT v3.20.2
9. INVESTMENT IN EQUITY SECURITIES
9 Months Ended
Sep. 30, 2020
Schedule of Investments [Abstract]  
INVESTMENT IN EQUITY SECURITIES

The Company, through its wholly owned subsidiary UWSS, made a $500,000 long-term investment in July 2020 to purchase certain non-marketable securities consisting of 7,142,857 Series B-2 Preferred Shares of Direct Dermatology Inc. (“DirectDerm”), representing 2.9% ownership of DirectDerm at that time. Through this investment, the Company received exclusive rights to utilize DirectDerm’s technology in all acute and post-acute care settings such as skilled nursing facilities, home health, and wound clinics. The Company does not have the ability to exercise significant influence over DirectDerm’s operating and financial activities.